Skip to Main Content

Paper Details

Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase.
Circulation
123
1986
2,3-dinor-6-keto-prostaglandin F 1 alpha, 2,3-dinor-thromboxane B2, Patients, Platelet, aspirin, circulating platelet aggregate, endoperoxide, endoperoxide/thromboxane A2 receptor, human, imidazo (1,5-2) pyridine-5-hexanoic acid, man, patients, peripheral vascular disease, plasma beta-thromboglobulin, platelet, platelet cyclooxygenase, prostacyclin, thromboxane, thromboxane A2, thromboxane B2, thromboxane synthase

Datasets

Release 1.2